Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/34651
Title: Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma
Authors: Samuel A. Henderson
Michael T. Tetzlaff
Penvadee Pattanaprichakul
Patricia Fox
Carlos A. Torres-Cabala
Roland L. Bassett
Victor G. Prieto
Hunter W. Richards
Jonathan L. Curry
University of Texas MD Anderson Cancer Center
Mahidol University
Lawrence Berkeley National Laboratory
Keywords: Medicine
Issue Date: 1-Jan-2014
Citation: Journal of Cutaneous Pathology. Vol.41, No.11 (2014), 846-852
Abstract: © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Background High mitotic figure count (MFC) correlates with low survival rate in Merkel cell carcinoma (MCC). However, the prognostic impact of histone biomarkers as surrogates of MFC in MCC is unknown. We evaluated the prognostic significance of the immunodetection of mitotic figures and of G2+ tumor nuclei with histone-associated mitotic markers H3K79me3T80ph (H3KT) and phosphohistone H3 (PHH3) in MCC.Methods Immunohistochemical analyses of H3KT and PHH3 and proliferative marker Ki-67 were performed in a series of 21 cases of MCC. The significance of the pathologic data and immunoreactivity with these markers was evaluated with Pearson correlation and paired Student t-test. Univariate Cox proportional hazards regression models were performed to assess the relationships between these markers and survival.Results H3KT detected a higher number of mitotic figure (p<0.0001) and G2+ tumor nuclei (p<0.0052) than did PHH3. Furthermore, the MFC combined with G2+ tumor nuclei detected with H3KT compared to PHH3 and manual MFC was a significant predictor of impaired survival in patients with MCC (p=0.035;HR=1.0172), corresponding to a 1.72% increased risk of death for each unit increase in H3KT.Conclusions Biomarker analysis of proliferative rates with histone markers may have relevance in stratifying risk in patients with MCC.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84913553400&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/34651
ISSN: 16000560
03036987
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.